1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6FF31A1143E00B6B185256F5E007EE3FB
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/pharma-biotech-alliance-management-key-factor?opendocument
18
19opendocument
2018.206.48.142
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Business Operations Alliances and Partnerships

Key Factors in Successful Pharma-Biotech Alliance Management

DB Image

ID: 4768


Features:

Graphics


Pages/Slides: 5


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

Non-members: Click here to sign-up for a complimentary tour of
"Key Factors in Successful Pharma-Biotech Alliance Management"


Study Overview
Major pharmaceutical companies are increasingly pressured to expand their product portfolios. Challenges for internal R&D include escalating costs, time and complexity required discovering, and developing and commercializing new drugs. Biotechnology companies need development and marketing assistance for their products. Marrying these two important goals is of the utmost importance for both partners. This five-page document provides business development executives with key findings pertaining to alliance creation and execution.

Key Topics

  • Personal relationship skills
  • Risk management
  • Goals and decision-making processes
  • Flexibility

Methodology
This research originated from Best Practices, LLC consulting work.

Industries Profiled:
Biotech; Pharmaceutical


Companies Profiled:
Atrix; AtheroGenics; Bristol-Myers Squibb; CV Therapeutics; Fujisawa; GlaxoSmithKline; Aderis; Cardiome; Micrologix

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.